v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash Flows From Operating Activities:    
Net loss $ (24,273,806) $ (7,991,736)
Adjustments to reconcile net loss to net cash used in operating activities:    
Impairment of in-process research and development 18,647,903
Stock-based compensation 205,478 544,902
Issuance of common stock pursuant to vendor agreements 240,000 79,200
Depreciation of fixed assets 6,933
Non-cash rent expense 7,839
Deferred tax (benefit) provision (851,659) 9,707
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (113,319) (52,035)
Accounts payable 371,006 676,178
Vendor deposits 7,048 (80,000)
Operating lease liability (8,656)
Accrued expenses and other current liabilities 1,066,657 502,839
Net Cash Used In Operating Activities (4,700,692) (6,304,829)
Cash Flows From Financing Activities:    
Exercise of warrants 2,672,500
Private placement of warrants 1,999,791
Warrant inducement offer - exercise proceeds 2,051,852 827,978
Exercise of pre-funded warrants 210
Deferred offering costs 12,511 (30,260)
Registration and issuance costs associated with warrant issuance (366,618) (180,142)
Net Cash Provided By Financing Activities 3,697,746 3,290,076
Net Decrease in Cash (1,002,946) (3,014,753)
Cash - Beginning of Period 1,530,924 3,137,674
Cash - End of Period 527,978 122,921
Supplemental Disclosures of Cash Flow Information:    
Interest
Income taxes
Non-cash investing and financing activities:    
Warrant modification - incremental value 1,816,646 246,912
Accounts payable and accrued expenses for offering costs $ 98,921 $ 176,870